Nasim Zargar

Nasim Zargar has a strong background in corporate strategy, M&A, and strategic planning. They most recently founded and became the CEO of Harp Health in 2022. Prior to this, Nasim worked at De La Rue as the Head of Corporate Strategy and M&A from 2019 to 2022. In this role, they directed the company's corporate strategy and M&A activities, leading the development and execution of the M&A strategy and corporate development initiatives. Before that, Nasim held the position of Strategy Manager at De La Rue from 2019 to 2019. They also worked as a Consultant in Strategy and M&A at Future Materials Group from 2016 to 2019. Nasim began their career as a Postdoctoral Product Development Scientist at the University of Oxford in 2011.

Nasim Zargar's education history follows a chronological order. In 2015, Nasim obtained the PRINCE2® Foundation & Practitioner certification. Furthermore, in the same year, they received a certification in Private Equity from Saïd Business School, University of Oxford. In 2012, Nasim obtained the Investment Management Certificate (IMCI) from CFA UK.

Moving on to their academic qualifications, Nasim Zargar earned a DPhil (PhD) in Engineering Science with a specialization in Biomedical Engineering (musculoskeletal sciences) from the University of Oxford. This degree was completed between 2008 and 2011.

Additionally, Nasim holds a Master of Science (MS) in Biomedical Engineering from the University of Oxford. However, the specific start and end years for this degree are not provided.

More recently, Nasim pursued an Executive MBA degree from Saïd Business School, University of Oxford. The program was undertaken between 2022 and 2024.

Overall, Nasim Zargar's educational background highlights their expertise in the field of Biomedical Engineering, coupled with their interest and proficiency in areas such as project management, private equity, and investment management.